Literature DB >> 3063913

Isolation and some properties of A and B subunits of Vero toxin 2 and in vitro formation of hybrid toxins between subunits of Vero toxin 1 and Vero toxin 2 from Escherichia coli O157:H7.

H Ito1, T Yutsudo, T Hirayama, Y Takeda.   

Abstract

Purified Vero toxin 2 (VT2) was separated into A and B subunits by treatment with 6 M urea in 0.1 M propionic acid (pH 4.0). The isoelectric points of the isolated A and B subunits were determined to be 8.1 and 4.1, respectively. The A subunit of the purified VT2 was not nicked, but could be nicked in vitro by trypsin. Biologically active toxin was reconstituted from the isolated A and B subunits of VT2. Hybrid toxins with biological activity were obtained in vitro from the A subunit of Vero toxin 1 (VT1) and the B subunit of VT2, and from the A subunit of VT2 and the B subunit of VT1. The hybrid toxins showed similar cytotoxicity to native VT1 and VT2 on Vero cells. The in vitro formations of hybrid toxins were confirmed by polyacrylamide disc gel electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3063913     DOI: 10.1016/0882-4010(88)90021-6

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  11 in total

1.  Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron.

Authors:  K Ramotar; B Boyd; G Tyrrell; J Gariepy; C Lingwood; J Brunton
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

2.  Structural basis of subtilase cytotoxin SubAB assembly.

Authors:  Jérôme Le Nours; Adrienne W Paton; Emma Byres; Sally Troy; Brock P Herdman; Matthew D Johnson; James C Paton; Jamie Rossjohn; Travis Beddoe
Journal:  J Biol Chem       Date:  2013-08-06       Impact factor: 5.157

3.  In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity.

Authors:  D L Weinstein; M P Jackson; L P Perera; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

4.  The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.

Authors:  Debaleena Basu; Xiao-Ping Li; Jennifer N Kahn; Kerrie L May; Peter C Kahn; Nilgun E Tumer
Journal:  Infect Immun       Date:  2015-10-19       Impact factor: 3.441

5.  Cytotoxic and apoptotic effects of recombinant subtilase cytotoxin variants of shiga toxin-producing Escherichia coli.

Authors:  J Funk; N Biber; M Schneider; E Hauser; S Enzenmüller; C Förtsch; H Barth; H Schmidt
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

6.  Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity.

Authors:  P R Austin; P E Jablonski; G A Bohach; A K Dunker; C J Hovde
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.

Authors:  Mari Ohmura; Masafumi Yamamoto; Chikako Tomiyama-Miyaji; Yoshikazu Yuki; Yoshifumi Takeda; Hiroshi Kiyono
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

8.  A reverse-sandwich enzyme-linked immunosorbent assay for verocytotoxin 1 and 2 antibodies in human and bovine sera.

Authors:  H Miyazawa; H Bannai; T Yanase; C Morita; S Satoh; J Sugiyama; S Taniguchi; S Inouye
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

Review 9.  Do the A subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2?

Authors:  Debaleena Basu; Nilgun E Tumer
Journal:  Toxins (Basel)       Date:  2015-04-29       Impact factor: 4.546

10.  Comparisons of native Shiga toxins (Stxs) type 1 and 2 with chimeric toxins indicate that the source of the binding subunit dictates degree of toxicity.

Authors:  Lisa M Russo; Angela R Melton-Celsa; Michael J Smith; Alison D O'Brien
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.